BD Exports FY2026-27 YTD (July-August) $9.16B +5.4% YoY BD Exports FY2025-26 (Full Year) $48.00B -0.6% YoY RMG Export (HS 61+62) $38.70B 80.6% of exports Top Destination United States $9.05B (+4.1%) Jute (HS 53) $751M Footwear (HS 64) $1.22B Leather Goods (HS 42) $400M Pharma (HS 30) $238M BGMEA Members 4,275 Japan EPA Active Feb 2026 EU EBA Duty-Free HS Codes 7,498 BD Exports FY2026-27 YTD (July-August) $9.16B +5.4% YoY BD Exports FY2025-26 (Full Year) $48.00B -0.6% YoY RMG Export (HS 61+62) $38.70B 80.6% of exports Top Destination United States $9.05B (+4.1%) Jute (HS 53) $751M Footwear (HS 64) $1.22B Leather Goods (HS 42) $400M Pharma (HS 30) $238M BGMEA Members 4,275 Japan EPA Active Feb 2026 EU EBA Duty-Free HS Codes 7,498
📰

Pharmaceuticals News

Breaking news, industry insights, policy updates, and market intelligence on Bangladesh's export economy — RMG, pharmaceuticals, leather, jute, agriculture, and emerging sectors. Curated for trade professionals, exporters, buyers, and policymakers.

Beacon Pharma profit doubles to Tk 1.94 billion in FY26 as sales surge 31 percent 💊 Pharmaceuticals

Beacon Pharma Profit Doubles To Tk 1.94 Billion In FY26 As Sales Surge 31 Percent

Beacon Pharmaceuticals reported a strong financial performance for FY26, with profit doubling to Tk 1.94 billion on a 31% increase in sales. The company has announced plans to invest Tk 2.5 billion in a new oncology production facility.

📅 Oct 16, 2026 ⏱️ 4 min
Bangladesh pharmaceutical industry sees limited gains from US tariff exemption on specialised medicines 💊 Pharmaceuticals

Bangladesh Drugmakers See Limited Gains From US Pharma Tariff Exemption Amid Capacity And Regulatory Hurdles

Bangladesh's pharmaceutical industry may see some opportunities from the latest US tariff adjustment that grants zero ad valorem tariff on certain pharmaceutical products from eligible jurisdictions, but industry leaders say immediate benefits are limited because local manufacturers do not produce the highly specialised drugs covered.

📅 Sep 30, 2026 ⏱️ 6 min
BSEC approves Beximco Pharma board overhaul with Salman F Rahman excluded from new nine-member board 💊 Pharmaceuticals

BSEC Clears Beximco Pharma Board Overhaul, Salman F Rahman Dropped From New Nine-Member Board

The Bangladesh Securities and Exchange Commission has approved a reconstituted nine-member board for Beximco Pharmaceuticals, excluding vice-chairman Salman F Rahman who is in custody. The move ends a prolonged regulatory and legal dispute over independent director appointments.

📅 Sep 29, 2026 ⏱️ 6 min
Philippines Ambassador Nina P Cainglet meeting Health Minister Sardar Md Sakhawat Husain seeking pharmaceutical cooperation 💊 Pharmaceuticals ⚡ Breaking

Philippines Seeks Bangladesh Cooperation in Pharmaceuticals Sector

Philippines Ambassador Nina P Cainglet seeks Bangladesh pharma cooperation as Philippines imports 67% of medicines from Western countries, emphasising direct Dhaka-Manila flights and nursing education MoU during meeting with Health Minister.

📅 Sep 2, 2026 ⏱️ 6 min
IFC provides $30.7 million senior secured loan to Popular Pharmaceuticals PLC for API imports August 2026 💊 Pharmaceuticals

Popular Pharmaceuticals Secures $30.7 Million IFC Loan for API Imports and Production Stability

IFC provides $30.7m senior secured loan to Popular Pharmaceuticals PLC for API imports. Popular: 815+ products, 155,600 pharmacies supplied, 10,000+ employees. Bangladesh pharma sector 90% dependent on imported APIs.

📅 Aug 18, 2026 ⏱️ 7 min
Pharmacy shelf with various branded medicine boxes highlighting drug pricing disparities in Bangladesh 💊 Pharmaceuticals

Why Do Medicine Prices Anger Bangladesh? Inside the Drug Pricing Puzzle

Bangladesh medicine prices 2-3x higher than India for same molecules. DGDA pricing loopholes, pharma oligopoly, weak generics push. BAPI President Abdul Muktadir defends industry; patient groups demand reform.

📅 Aug 10, 2026 ⏱️ 9 min
Renata PLC pharmaceutical manufacturing facility in Bangladesh exporting therapeutics to Portugal EU market August 2026 💊 Pharmaceuticals

Renata PLC Enters Portugal Market with First Shipment of Therapeutics

Renata PLC entered Portugal with first shipment of 3 therapeutics: Amantadine (Parkinson's), Fludrocortisone (Addison's), Cabergoline (hyperprolactinemia). Already exports to 8 European markets including UK, France, Ireland.

📅 Aug 4, 2026 ⏱️ 6 min